Profusa (NVACW) Deferred Taxes (2023 - 2024)
Profusa (NVACW) reported Deferred Taxes of $13661.0 for Q1 2024, up 138.38% on a YoY basis from $5730.8 in Q2 2023, and up 200.0% quarter-over-quarter from -$13661.0 in Q4 2023.
Profusa (NVACW) Deferred Taxes (2023 - 2024) Analysis & Trends
Profusa has reported Deferred Taxes for 2 years, with the latest figure at $13661.0 in Q1 2024.
- For the quarter ending Q1 2024, Deferred Taxes rose 138.38% year-over-year to $13661.0; the trailing twelve-month figure through Dec 2024 stood at $13661.0 (down 41.32% YoY), and the FY2024 full-year result was $13661.0, down 41.32% from the prior year.
- Deferred Taxes for Q1 2024 stood at $13661.0, up from -$13661.0 in the prior quarter.
- The five-year high for Deferred Taxes was $72537.0 in Q2 2023, with the low at -$35597.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -101.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 300,000.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -16.70 Mn |
| 10 | Profusa | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 13,661.00 |
| Dec 31, 2023 | -13,661.00 |
| Jun 30, 2023 | 72,537.00 |
| Mar 31, 2023 | -35,597.00 |